4.6 Review

The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems

Journal

EXPERT OPINION ON DRUG DELIVERY
Volume 15, Issue 5, Pages 469-479

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2018.1446936

Keywords

Drug delivery systems; nanoparticles; microfluidics; co-flow geometry; nanoprecipitation

Funding

  1. Academy of Finland [304844]
  2. University of Helsinki Research Funds
  3. Sigrid Juselius Foundation [4704580]
  4. European Research Council under the European Union's Seventh Framework Programme [310892]
  5. HiLIFE Research Funds

Ask authors/readers for more resources

Introduction: Nanoparticles are anticipated to overcome persistent challenges in efficient drug delivery, but the limitations associated with conventional methods of preparation are resulting in slow translation from research to clinical applications. Due to their enormous potential, microfluidic technologies have emerged as an advanced approach for the development of drug delivery systems with well-defined physicochemical characteristics and in a reproducible manner.Areas covered: This review provides an overview of microfluidic devices and materials used for their manufacturing, together with the flow patterns and regimes commonly used for nanoparticle preparation. Additionally, the different geometries used in droplet microfluidics are reviewed, with particular attention to the co-flow geometry used for the production of nanoparticles. Finally, this review summarizes the main and most recent nanoparticulate systems prepared using microfluidics, including drug nanosuspensions, polymeric, lipid, structured, and theranostic nanoparticles.Expert opinion: The production of nanoparticles at industrial scale is still a challenge, but the microfluidic technologies bring exciting opportunities to develop drug delivery systems that can be engineered in an easy, cost-effective and reproducible manner. As a highly interdisciplinary research field, more efforts and general acceptance are needed to allow for the translation of nanoparticulate drug delivery systems from academic research to the clinical practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available